Too many lung biopsies have to be repeated.
Up to
40%
of lung biopsy samples are returned as insufficient for analysis1
Every repeat biopsy means
-
More time lost to another procedure and more appointments.
-
Added costs for patients, clinics and health systems.
-
A later diagnosis, and a later start to treatment.
-
More stress and anxiety while patients wait for answers.
Source: 1 Ishiwata et al., CHEST 2023
Lung cancer is the leading cause of cancer death in the U.S., and time matters.
About
229,000
new lung cancer cases expected in the U.S. in 20261
About
125,000
U.S. lung cancer deaths expected in 2026, more than any other cancer1
After a 6-week delay
13%
higher 5-year mortality in stage I lung cancer2
Sources: 1 American Cancer Society, 2026 · 2 Khorana et al., PLoS One 2019
Check the sample while the patient is still in the room.
The verifi LUNG test checks the biopsy specimen during the procedure, so the care team knows the sample is sufficient before the patient goes home.
-
Verified in 5 minutes
Confirms the specimen during the biopsy.
-
Built for every procedure room
Disposable cartridges on a small, portable reader.
-
A faster path to treatment
Fewer repeat biopsies, so treatment starts sooner.
*Products not FDA cleared or approved in any jurisdiction
One biopsy, not two.
Testing the specimen in the procedure room removes the wait, and the repeat visit.
Today
- 1Biopsy performed
- 2Sample sent to pathology lab
- 3Waiting for results
- !Up to 40% insufficient
- ↻Patient returns for repeat biopsy
With verifi LUNG test
- 1Biopsy performed
- 25-minute cartridge test in the room
- 3Specimen confirmed before the procedure ends
- ✓Sample to lab, on to diagnosis